IDEAS home Printed from https://ideas.repec.org/f/pma2817.html
   My authors  Follow this author

T. Joseph Mattingly, II

Personal Details

First Name:T. Joseph
Middle Name:
Last Name:Mattingly
Suffix:II
RePEc Short-ID:pma2817
[This author has chosen not to make the email address public]
https://faculty.rx.umaryland.edu/tmattingly/

Affiliation

University of Maryland School of Pharmacy - Pharmaceutical Health Services Research

https://www.pharmacy.umaryland.edu/about/depts/phsr/
United States, Baltimore, Maryland
220 Arch Street, 12th Floor

Research output

as
Jump to: Articles

Articles

  1. Mark T. Linthicum & Susan dosReis & Julia F. Slejko & T. Joseph Mattingly & Jennifer L. Bright, 2021. "The Importance of Collaboration in Pursuit of Patient-Centered Value Assessment," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(4), pages 381-384, July.
  2. T. Joseph Mattingly & Karen Li & Arnold Ng & Tieu-Long Ton-Nu & Jennifer Owens, 2021. "Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe®," PharmacoEconomics - Open, Springer, vol. 5(2), pages 245-250, June.
  3. Moaz Abdelwadoud & T. Joseph Mattingly & Hemanuel Arroyo Seguí & Emily F. Gorman & Eleanor M. Perfetto, 2021. "Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(5), pages 471-484, September.
  4. T. Joseph Mattingly & Julia F. Slejko & Eberechukwu Onukwugha & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2020. "Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 38(2), pages 233-242, February.
  5. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.
  6. T. Joseph Mattingly & Khang Nong, 2019. "Implementing a Health Confidence Tool at Time of Discharge," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 12(1), pages 163-165, February.
  7. T Joseph Mattingly II & Stephen Meninger & Emily L Heil, 2019. "Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-9, January.
  8. T. Joseph Mattingly & Julia F. Slejko & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2019. "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 12(6), pages 631-638, December.
  9. T. Joseph Mattingly & Joseph F. Levy & Julia F. Slejko & Nneka C. Onwudiwe & Eleanor M. Perfetto, 2018. "Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?," PharmacoEconomics, Springer, vol. 36(9), pages 1093-1099, September.
  10. T. Joseph Mattingly & C. Daniel Mullins & Eberechukwu Onukwugha, 2016. "Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?," PharmacoEconomics, Springer, vol. 34(10), pages 1067-1070, October.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. T. Joseph Mattingly & Karen Li & Arnold Ng & Tieu-Long Ton-Nu & Jennifer Owens, 2021. "Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe®," PharmacoEconomics - Open, Springer, vol. 5(2), pages 245-250, June.

    Mentioned in:

    1. Journal round-up: PharmacoEconomics – Open 5(2)
      by Rita Faria in The Academic Health Economists' Blog on 2021-07-26 06:00:01
  2. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.

    Mentioned in:

    1. Rita Faria’s journal round-up for 14th September 2020
      by Rita Faria in The Academic Health Economists' Blog on 2020-09-14 11:00:07
  3. T. Joseph Mattingly & Julia F. Slejko & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2019. "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 12(6), pages 631-638, December.

    Mentioned in:

    1. Rita Faria’s journal round-up for 30th December 2019
      by Rita Faria in The Academic Health Economists' Blog on 2019-12-30 12:00:00

Articles

  1. T. Joseph Mattingly & Julia F. Slejko & Eberechukwu Onukwugha & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2020. "Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 38(2), pages 233-242, February.

    Cited by:

    1. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.
    2. Susan dosReis & Beverly Butler & Juan Caicedo & Annie Kennedy & Yoon Duk Hong & Chengchen Zhang & Julia F. Slejko, 2020. "Stakeholder-Engaged Derivation of Patient-Informed Value Elements," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 13(5), pages 611-621, October.

  2. T. Joseph Mattingly & Julia F. Slejko & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2019. "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 12(6), pages 631-638, December.

    Cited by:

    1. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.
    2. T. Joseph Mattingly & R. Brett McQueen & Pei-Jung Lin, 2021. "Contextual Considerations and Recommendations for Estimating the Value of Alzheimer’s Disease Therapies," PharmacoEconomics, Springer, vol. 39(10), pages 1101-1107, October.
    3. Moaz Abdelwadoud & T. Joseph Mattingly & Hemanuel Arroyo Seguí & Emily F. Gorman & Eleanor M. Perfetto, 2021. "Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(5), pages 471-484, September.
    4. T. Joseph Mattingly & Julia F. Slejko & Eberechukwu Onukwugha & Eleanor M. Perfetto & Shyamasundaran Kottilil & C. Daniel Mullins, 2020. "Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 38(2), pages 233-242, February.

  3. T. Joseph Mattingly & Joseph F. Levy & Julia F. Slejko & Nneka C. Onwudiwe & Eleanor M. Perfetto, 2018. "Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?," PharmacoEconomics, Springer, vol. 36(9), pages 1093-1099, September.

    Cited by:

    1. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.
    2. Gianluca Antonecchia & Ajay Bhaskarabhatla & Enrico Pennings, 2024. "Bargaining Power and Quantity Discounts to Retailers: Evidence from India’s Pharmaceutical Industry," Tinbergen Institute Discussion Papers 24-048/VII, Tinbergen Institute.
    3. Salas-Vega, Sebastian & Shearer, Emily & Mossialos, Elias, 2020. "Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US," Social Science & Medicine, Elsevier, vol. 258(C).
    4. Sabine Vogler & Peter Schneider & Nina Zimmermann, 2019. "Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing," PharmacoEconomics - Open, Springer, vol. 3(3), pages 303-309, September.
    5. Wei Gao & Dominic Muston & Matthew Monberg & Kimmie McLaurin & Robert Hettle & Elizabeth Szamreta & Elyse Swallow & Su Zhang & Iden Kalemaj & James Signorovitch & R. Brett McQueen, 2020. "A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer," PharmacoEconomics, Springer, vol. 38(11), pages 1201-1218, November.
    6. Paweł Żelewski & Michał Wojna & Katarzyna Sygit & Elżbieta Cipora & Izabela Gąska & Mateusz Niemiec & Mateusz Kaczmarski & Tomasz Banaś & Beata Karakiewicz & Artur Kotwas & Paulina Zabielska & Olga Pa, 2022. "Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union," IJERPH, MDPI, vol. 19(19), pages 1-17, September.

  4. T. Joseph Mattingly & C. Daniel Mullins & Eberechukwu Onukwugha, 2016. "Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?," PharmacoEconomics, Springer, vol. 34(10), pages 1067-1070, October.

    Cited by:

    1. Kristina R. Dahlstrom & Shuangshuang Fu & Wenyaw Chan & Zeena Shelal & Lois M. Ramondetta & David R. Lairson, 2018. "Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients," PharmacoEconomics, Springer, vol. 36(11), pages 1355-1365, November.
    2. T. Joseph Mattingly & Bryan L. Love & Bilal Khokhar, 2020. "Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review," PharmacoEconomics, Springer, vol. 38(9), pages 927-939, September.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, T. Joseph Mattingly II should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.